2011 / Narrative review
A review summarizes human pharmacokinetic and pharmacodynamic data for resveratrol, noting a lack of clinical evidence and conflicting capsule versus food data.
This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.
Chachay VS, Kirkpatrick CM, Hickman IJ, et al. Br J Clin Pharmacol, 2011. PMID 21410504